To examine the biochemical pathways by which activated Ha-Ras(G12V) (Ha-RasV12) induces factor-independent growth of myeloid cells, Ha-Ras eector loop mutations, including Y40C, T35S, and E37G, were analysed in a mouse factor-dependent myeloid cell line, WT19. Expression of a single eector loop mutant, HaRas(G12V, Y40C) (Ha-RasV12C40), inhibited factorwithdrawal apoptosis, suggesting that activation of the phosphatidylinositol 3'-kinase (Pl3K) pathway is essential to prevent cell death. Neither Ha-Ras (G12V, T35S) (Ha-RasV12S35), which activates the Raf1 signaling pathway, nor Ha-Ras(G12V, E37G) (Ha-RasV12G37), which stimulates the RalGDS pathway, did not have signi®cant eects on factor-withdrawal apoptosis of myeloid cells. Although Ha-RasV12C40 inhibited apoptosis, it did not stimulate entry into the cell cycle. Cell lines containing the combination of Ha-RasV12G37 and Ha-RasV12C40 were capable of factor-independent cell growth, while expression of the other combinations of the Ha-Ras eector mutants were not. The combined expression of Bcl-2 and Ha-RasV12G37 was not sucient to stimulate factor independent growth, suggesting that Ha-RasV12C40 activates additional signals, besides blocking apoptosis, which are critical for factor-independent growth of myeloid cells. In factorstarved myeloid cells, inducible expression of HaRasV12G37 results in decreased level of p27
Introduction
WT19, a derivative of a mouse factor-dependent myeloid cell line, FDC-P1 (Dexter et al., 1980) is a useful cellular model to study the biochemical pathways necessary for the growth of myeloid cells (Bourette et al., 1995; Matsuguchi et al., 1997) . It is dependent on mouse lL-3 (mlL-3) or mouse GM-CSF (mGM-CSF) for proliferation and survival. In the absence of these factors, WT19 cells accumulate in G1 and then rapidly undergo apoptosis (Matsuguchi et al., 1997) . Ras plays an important role in regulating myeloid cell growth, as the expression of an oncogenic Ha-Ras(G12V) (Ha-RasV12) makes FDC-P1 cells grow factor-independently by a nonautocrine mechanism (Boswell et al., 1990) .
The Ras proteins, encoded by Harvey (Ha)-ras, Kirsten (Ki)-rasA, Ki-rasB, and N-ras, are essential transducers of extracellular signals controlling cell growth and dierentiation (Boguski and McCormick, 1993) . The Ras proteins are activated through conversion of the inactive GDP-bound form into the active GTP-bound form (Boguski and McCormick, 1993) . Activating mutations of ras which lead to an increase in the GTP-bound form, are found in a wide variety of tumors including myeloid leukemia, suggesting that Ras plays an important role in their pathogenesis (Barbacid, 1987; Bos, 1989) . Ras functions through multiple downstream eectors via its amino-terminal eector loop domain (amino acids 32 ± 40 in Ha-Ras) (Rodriguez-Viciana et al., 1994; White et al., 1995; Joneson et al., 1996) . This nine amino acid stretch is identical in all known Ras proteins and undergoes a major conformational change when Ras is activated by binding GTP. The known Ras eectors include Raf1 (Koide et al., 1993; Vojtek et al., 1993) , the p110 catalytic domain of phosphatidyl inositol 3' kinase (Pl3K) (Rodriguez-Viciana et al., 1994) , and RalGDS (Hofer et al., 1994) . Speci®c mutations within the Ras eector loop domain eliminate binding to speci®c eectors without disturbing the binding to others (Polakis and McCormick 1993) .
In this report, the biochemical pathways responsible for Ha-RasV12-mediated factor-independent myeloid cell growth have been explored. Three Ha-Ras eector loop domain mutants, Ha-RasV12S35, HaRasV12C40, and Ha-RasV12G37, which retain the interaction with Raf1, p110 Pl3K , and RalGDS respectively (White et al., 1995 Joneson et al., 1996; Khosravi-Far et al., 1996) , were expressed in WT19 cells. Our results demonstrate that both HaRasV12C40 and Ha-RasV12G37 are necessary for the factor independent growth of WT19 cells. The presence of Ha-RasV12C40 inhibits factor-withdrawal apoptosis, while Ha-RasV12G37 causes decreased levels of p27 Kip1 , a cyclin-dependent kinase inhibitor (CKI).
Results
The expression of Ha-RasV12 in WT19 cells results in factor-independent growth A mouse myeloid cell line, WT19, derived from the FDC-P1 cell line, depends on mlL-3 or mGM ± CSF for cell growth (Bourette et al., 1995; Matsuguchi et al., 1997) . Removal of these factors leads to rapid apoptosis within 24 h (Matsuguchi et al., 1997) . To examine the roles of Ras-mediated pathways in regulating the growth, WT19 cells were transfected with an expression vector encoding the Ha-ras transforming oncogene, Ha-rasV12 ( Figure 1a , lane 2). Three independent transfectants were examined and the data from a representative clone is detailed. All clones containing Ha-RasV12 grew in the absence of mlL-3 or mGM-CSF (Figure 2a ). This factorindependent growth was not secondary to autocrine mechanisms as evidence by the observation that the culture supernatant from Ha-RasV12-expressing cells did not support the survival of parental WT19 cells (data not shown).
Expression of Ha-Ras eector loop mutants in WT19 cells
To explore the downstream signals of Ha-RasV12 responsible for the factor-independent growth of WT19 cells, three Ha-rasV12 expression plasmids containing eector domain mutations were introduced into WT19 cells. Ha-RasV12S35 retains the ability to interact with Raf1, but is defective in p110 Pl3K or RalGDS binding (White et al., 1995; Khosravi-Far et al., 1996) HaRasV12C40 interacts with p110
Pl3K but not with Raf1 or RalGDS (Joneson et al., 1996; Khosravi-Far et al., 1996) . Ha-RasV12G37 interact with RalGDS but not with Raf1 or p110
Pl3K Khosravi-Far et al., 1996) . To detect these mutant proteins in the background of the endogenous Ras, the cDNAs were tagged with either HA or Flag. Cell lines were derived which expressed either individual mutant proteins or combinations of the mutants. The double mutant cells were identi®ed by the detection of both Flag and HA antigens on Western blots (Figure 1 , lanes 6 ± 8). A small amount of additional 21 kD protein was observed using the anti-Ras antibody in tagged HaRas transfectants and was presumed to be a degradation product of the transfected Ha-Ras proteins.
It was relatively dicult to obtain WT19 cell lines stably expressing large amounts of Ha-RasV12G37. Eorts to express this protein under the CMV promoter which was used for the other two mutants failed, although this plasmid (pDCR-Ha-rasV12G37) expressed a signi®cant amount of protein in 293 cells in transient expression assays (data not shown). Several Ha-RasV12G37-expressing cell lines were successfully obtained using a plasmid containing the elongation factor 2 (EF2) promoter (pEFBOS-Flag-RasV12G37) (Figure 1, lane 5) . However, these cell lines did not express Ha-RasV12G37 to the same level as the HaRasV12S35 or Ha-RasV12C40 cell lines (Figure 1 , top panel), suggesting that the overexpression of HaRasV12G37 may be toxic to WT19 cells. Higher levels of Ha-RasV12G37 expression were easily obtained with the simultaneous expression of either Ha-RasV12S35 or Ha-RasV12C40 (Figure 1 , lanes 6 ± 8).
Characterization of single and double mutant Ha-Ras containing cell lines
The ability of Ha-rasV12-transfected WT19 cells to grow in the absence of mlL-3 suggested that activated Ha-Ras provides signals which promote both cell cycle progression and cell survival. To determine which downstream signals of Ha-RasV12 are essential for factor-independent cell growth, the growth of the individual Ha-Ras eector domain mutants was characterized in the absence of mlL-3. WT19 cells expressing Ha-RasV12C40 had a slower rate of apoptosis after mlL-3 removal (Figure 2a) . The decreased rate of apoptosis in the Ha-RasV12C40 clones was also evident in DNA fragmentation analyses (Figure 2b ). However, in spite of their prolonged cell survival, they did not transit the cell cycle and were all blocked in the G1 phase of the cell cycle (Figure 2c ), dying in 3 ± 4 days after the factor withdrawal. The Ha-RasV12S35 clones showed slightly prolonged cell survival ( Figure 2a ) and decreased DNA fragmentation (Figure 2b ) in the absence of mlL-3 compared to the parental WT19 cells. Like the Ha-Ras V12C40, Ha-RasV12S35 cells accumulated in G1 phase without mlL-3 stimulation (Figure 2c ) WT19 cells expressing Ha-RasV12G37 did not show any prolonged cell survival or cell cycle progression without mlL-3 (Figure 2 ). The ability of each of these clones to block apoptosis is also demonstrated by the size of the sub-G0 peak, an indication of the number of apoptotic cells (Figure 2c ).
Combined expression of Ha-RasV12C40 and HaRasV12G37 eliminates the requirement for mlL-3 in WT19 cells
Since none of the single Ha-Ras V12 eector loop mutants allowed factor-independent growth of WT19 cells, cell lines were created which expressed two of the Ha-Ras eector mutants (Figure 1, lanes 6 ± 8) . These cell lines were tested for growth in the absence of mlL-3 (Figure 3 ). When WT19 cells were transfected with the expression plasmids coding for Ha-RasV12C40 and Ha-RasV12G37, the positive clones were able to grow in the absence of mlL-3 at approximately the same rate as the Ha-RasV12-expressing clones ( Figure 2a and Figure 3 ). The co-expression of Ha-RasV12C40 and Ha-RasV12G37 induced cell cycle progression from G1 to S phase and decreased DNA fragmentation in the absence of mlL-3 (data not shown). In contrast, the coexpression of Ha-RasV12S35 and Ha-RasV12C40, or Ha-RasV12S35 and Ha-RasV12G37 did not result in the factor-independent growth of WT19 cells ( Figure  3 ).
Regulation of ERK and AKT kinase activity by Ha-Ras eector loop mutants
In Ha-RasV12S35-expressing cell lines, modest activation of ERK has been demonstrated (White et al., 1995; Kinoshital et al., 1997) presumably as a result of Raf1 activation (Dent et al., 1992; Howe et al., 1992; Kyriakis et al., 1992) . To examine the ERK activation in these transfected cells, lysates from factor-deprived WT19 cells were blotted with the anti-phospho-ERK antibody. Similar to the results obtained by others (White et al., 1995; Kinoshita et al., 1997) , cells carrying Ha-RasV12, or Ha-Ras V12S35 showed increased ERK phosphorylation (Figure 4a ), and thus enhanced activity of this enzyme (Boulton et al., 1991) . In contrast, in cells containing Ha-RasV12G37 or HaRas V12C40 these proteins did not stimulate the ERK phosphorylation. Additionally, ERK phosphorylation was not activated in cells carrying both Ha-RasV12C40 and Ha-RasV12G37, suggesting that activation of ERK may not be necessary for factor-independent cell growth.
Recently, it has been demonstrated that inositol lipids generated by Pl3K activate a biochemical pathway stimulating Akt (also known as protein kinase B) (Burgering and Coer 1995). Akt-induced protein phosphorylation mediates inhibition of apoptosis in various cell lines (Kennedy et al., 1997; Dudek et al., 1997; Kaumann-Zeh et al., 1997) . Therefore, the activation of Akt may be one mechanism by which Ha-RasV12 regulates cell survival. To test this possibility, the eector loop mutant cell lines were starved, and the anti-Akt immunoprecipitates were tested for kinase activity using histoneH2B as the substrate (Burgering and Coer 1995) . The cells expressing Ha-RasV12C40 showed modest increases in Akt kinase activity, suggesting that they had increased Pl3K activity (Figure 4b, lane 4) . In contrast, cells expressing neither Ha-RasV12S35 nor Ha-RasV12G37 showed increased Akt activity. Double Ha-Ras mutant transfectants containing HaRasV12C40 mutant also had increased Akt activity (Figure 4b, lanes 6 and 8) . Therefore, the activation of Akt alone is not sucient for cell growth, but is found in cell lines which have prolonged survival in the absence of mlL-3.
The eects of Ha-RasV12C40 are not mediated through increased Bcl-2 protein level
The exact mechanism of the anti-apoptotic eect of Akt is not completely known. Akt activity was linked to increased Bcl-2 protein levels in some studies (Ahmed et al., 1997; Skorski et al., 1997) , but not in others (Kennedy et al., 1997) . Akt has also been shown to phosphorylate Bad a pro-apoptotic Bcl-2-related protein, inhibiting its activity (Data et al., 1997; del Peso et al., 1997) . The addition of lL-3 to factordependent cell lines increases Bcl-2 mRNA and protein levels (Rinaudo et al., 1995) , suggesting that one antiapoptotic mechanism of mlL-3 is increasing Bcl-2. In a more recent report, however, Bcl-X L but not Bcl-2 was induced by lL-3 stimulation (Leverrier et al., 1997) .
To examine the level of endogenous Bcl-2 in cells expressing the Ha-Ras eector domain mutants, lysates from factor-deprived cells were separated by SDS ± PAGE and blotted with an antibody that recognizes murine Bcl-2 (Figure 5b ). No signi®cant dierence was seen in the levels of endogenous Bcl-2 in the Ha-Ras eector loop mutant transfectants. To test if the antiapoptotic eect of Bcl-2 can replace the role of HaRasV12C40 in factor-independent growth of WT19 cells, human Bcl-2 protein was constitutively overexpressed in each of the single eector mutant cell Figure 3 The long-term proliferation and the viability of WT19 cells expressing two Ha-Ras eector loop mutants in the absence of mIL-3. Viable cell numbers (upper panels) and the viability (lower panels) were measured by the trypan blue exclusion assay. The cell number at day 0 is de®ned as 100 for each cell line. Each point represents the mean value of triplicate experiments, and the SD for cell numbers is shown by an error bar 7 cells and the kinase reaction was performed using histone H2B (5 mg) as the substrate lines. Western blots were performed and showed that human Bcl-2 was expressed to a similar level in each of the eector cell lines (Figure 5a ). Bcl-2 overexpression signi®cantly prolonged survival of WT19 cells in the absence of mlL3 (Figure 5c ). Best seen on days 2 and 3 of growth factor starvation, the coexpression of Bcl-2 with Ha-RasV12G37 induced a signi®cant increase in survival when compared to Bcl-2 alone or to other HaRas eector mutants having Bcl-2 overexpression. However, although Bcl-2/Ha-RasV12G37 clones survived longer than other cell lines, the expression of Bcl-2 was not sucient to induce continued cell growth (Figure 5c ). Thus, these results suggest that HaRasV12C40 protein supplies additional biochemical signals to complement the RasV12G37 and allow for factor-independent cell growth.
Expression of Ha-RasV12G37 decreases P27
Kip1 protein levels Although Ha-RasV12G37 alone had no eect on the survival of WT19 cells (Figures 2 and Figure 3 ), it stimulated cell proliferation when co-expressed with Ha-RasV12C40 in the absence of mlL-3. To attempt to determine what biochemical events were stimulated by Ha-RasV12G37, the cDNA of Ha-RasV12G37 was cloned into a metallothionein-inducible expression vector. Stable transfectants of this plasmid (pMEPFlag-Ha-rasV12G37) were examined for the inducible expression of Ha-RasV12G37 by ®rst starving the WT19 cells and then treating them with cadmium (Cd 2+ ). The protein expression was determined by Western blotting using anti-Flag antibody (Figure 6a ). These cell lines expressed low levels of Ha-RasV12G37 in the absence of metal addition. However, cadmium (10 mM) addition induced a signi®cant increase in HaRasV12G37 expression within 8 h (Figure 6a) .
The removal of mlL-3 from WT19 cells causes a large increase in p27
Kip1 protein (data now shown). p27
Kip1 is thought to inhibit cyclin-dependent kinase (cdk) complexes, for example cyclin E/cdk2, which are necessary for the transition from G1 into S . The activation of Ras in starved cells causes a decrease in the level of p27
Kip1 which is necessary for the cells to enter S phase (Takuwa and Takuwa 1997; Leone et al., 1997; Aktas et al., 1997) . To determine whether the expression of Ha-RasV12G37 alone is sucient to modulate p27 Kip1 levels, extracts from factor-deprived cells treated with cadmium were examined by Western blotting with the anti-p27 Kip1 antibody. The p27
Kip1 protein levels were signi®cantly reduced by cadmium addition in the pMEP-Flag-HarasV12G37 transfectants, but not in the control parental cells (Figure 6b ). This phenomon was not merely a consequence of cell-cycle progression, as the induction of Ha-RasV12G37 protein with cadmium did not initiate signi®cant changes of the cell population in each cell cycle phase (Figure 6c ). The levels of p27 in pMEP-Flag-Ha-rasV12G37 transfectants were 75% of parental cells apparently because this vector is leaky in the absence of cadmium.
The downregulation of p27 Kip1 protein was mediated by a post-transcriptional mechanism because there was no detectable decrease of p27
Kip1 mRNA induced by Ha-RasV12G37 expression (data not shown). The protein level of another CKI, p21
Waf1
, did not change in the pMEP-Flag-Ha-rasV12G37 transfectants after cadmium addition (data not shown), suggesting the decrease was speci®c to p27 Kip1 . Neither the protein level of CDC25A nor mRNA levels of Cyclins A, D1, E, which are positive regulators of cell cycle progression, changed with the induction of HaRasV12G37 expression (data not shown). Therefore, it is likely that an important function of HaRasV12G37 is to activate pathways which lead to p27 degradation. It is of note that only slight changes in the S phase cell number were detected inspite of the decreased p27
Kip1 level (Figure 6c ), thus suggesting that additional signals may be necessary to activate the G1/ S phase transition of WT19 cells.
Discussion
WT19 cells expressing Ha-RasV12C40 demonstrated signi®cantly prolonged cell survival and delayed onset of apoptosis in the absence of mlL-3 (Figure 2a, b) . The same phenomenon has recently been reported in the mlL-3-dependent Ba/F3 cell line using another Ras eector domain mutant which also interacts with p110 Pl3K , Ha-Ras(G12V, V45E) (Kinoshita et al., 1997) . Recent results have suggested that the production of phosphatidylinositol 3,4-biphosphate and phosphatidylinositol 3,4,5-triphosphate by Pl3K activates Akt (Burgering and Coee 1995) which then phosphorylates Bad, a mitochondrial membrane bound protein del Peso et al., 1997) . The phosphorylation of Bad leads to the suppression of growth factor-withdrawal apoptosis in hematopoietic cells (Zha et al., 1996) . Our results are consistent with the idea that the Pl3K-Akt pathway is an important regulator of cell survival in myeloid cells.
Cell proliferation was not induced in growth factor starved WT19 cells with either Ha-RasV12S35 or HaRasV12C40 expression alone or in combination (Figures 2 and 3) . However, in ®broblasts, although neither Ha-RasV12S35 nor Ha-RasV12C40 alone induced DNA synthesis individually, the combination of the two Ha-Ras mutants induced DNA synthesis similarly to Ha-RasV12 (Joneson et al., 1996) . These ®ndings suggest that cell proliferation may be regulated by dierent Ha-Ras eector pathways in ®broblasts and myeloid cells. Interestingly, contransfection of HaRasV12C40 and Ha-RasV12G37 resulted in synergistic cooperation of their focus-forming activity on a strain of NIH-3T3 ®broblasts (Khosravi-Far et al., 1996) .
The expression of Ha-RasV12G37 did not activate either ERK or Akt (Figure 4 ), or prolong cell survival in the absence of mlL-3 (Figure 2 ). However, in multiple WT19 clones, combined expression of HaRasV12C40 and Ha-RasV12G37 promoted long-term survival of WT19 cells in the absence of mlL-3 ( Figure  3) . Interestingly, this combination of Ha-Ras eector mutants allowed factor-independent cell growth without signi®cant ERK activation (Figure 4) , suggesting that the activation of ERK may not be necessary for WT19 cell growth. However, the use of dominant negative ERK in wild type cells would further help to clarify this point. Therefore, while the activation of Pl3K pathway can mediate anti-apoptotic signals in this myeloid cell line, the activation of additional downstream pathways other than ERK activation is necessary to initiate the cell proliferation signal.
Overexpression of Bcl-2 signi®cantly prolonged the survival of factor-deprived WT19 cells (Figure 5c ). However, Bcl-2 could not cooperate with HaRasV12G37 to induce the long-term factor-independent growth of WT19 cells. This result suggests that the inhibition of apoptosis is not the single important function of Ha-RasV12C40 sucient to induce the long-term factor-independent growth of WT19 cells in collaboration with Ha-RasV12G37. Because the activation of Akt also aects both glucose transport and protein synthesis (Cong et al., 1997; Kohn et al., 1996; Tanti et al., 1997; Ueki et al., 1998) , it is possible that Ha-RasV12C40 stimulates multiple biologic pathways necessary for cell growth.
Several Ras-interacting proteins have been reported to bind the Ha-Ras V12E37G mutant in the yeast two hybrid system. For example, byr2, a putative S. pombe serine/threonine kinase homologous to the mammalian MEK kinase (MEKK) (White et al., 1995) ; S. cerevisae adenyl cyclase (CYR1) (White et al., 1995) ; RalGDS, a mammalian guanine nucleotide exchange factor of the Ras-related GTPase Ral , and its homologues, Rlf (Wolthuis et al., 1997) and Rgl (Murai et al., 1997) have all been shown to interact with Ha-RasV12G37. While the overexpression of RalGDS was not capable of transforming NIH-3T3 cells, it greatly enhanced the focus-formation induced by an activated Raf variant which was weakly transforming by itself . The recently isolated Rlf gene, which is approximately 30% identical in amino acid sequence to RalGDS, also exhibits guanine nucleotide exchange activity toward Ral (Wolthuis et al., 1996 (Wolthuis et al., , 1997 . A membrane-targeted form of Rlf (Rlf-CAAX) stimulated the proliferation of NIH-3T3 cells under low-serum conditions (Wolthuis et al., 1997) . Also, an active form of RalA, a substrate of RalGDS and Rlf, enhances the transforming activity of Raf1 (Urano et al., 1996) , supporting the contention that RalGDS family proteins play an important role in the Ras-mediated cell ± growth signal. Although RalGDS and Rlf enhanced the transforming activity of Raf1 in ®broblasts, Ha-RasV12G37 did not cooperate with Ha-RasV12S35, a Raf activator, to stimulate the factor-independent growth of WT19 cells. These data suggest that the pathways needed to stimulate transformation of ®broblasts, and the factor-independent growth of myeloid cells may be dierent.
We demonstrated that inducible expression of HaRasV12G37 mediated the downregulation of p27 Kip1 protein ( Figure 6 ). In mlL-3-starved WT19 cells, the level of p27
Kip1 rises, while the addition of mlL-3 to these cells causes a marked reduction of p27 Kip1 (data not shown). A similar phenomenon was reported in lymphocytes stimulated by IL-2 (Nourse et al., 1994) , suggesting that some cytokines may downregulate p27 Kip1 . Recently, it has been demonstrated that Ras
Regulation of myeloid cell growth by Ras mutants T Matsuguchi and AS Kraft activation is required for the downregulation of p27 Kip1 protein (Takuwa and Takuwa 1997; Leone et al., 1997; Aktas et al., 1997) . p27
Kip1 binds to cyclin/cdk complexes and inhibits their activity (Toyoshima and Hunter 1994; Polyak et al., 1994) . Interestingly, degradation of p27 Kip1 may occur when it is phosphorylated by cyclinE/cdk2 (Vlach et al., 1997; Shea et al., 1997) . This phosphorylation targets p27
Kip1 to ubiquitin-mediated degradation (Vlach et al., 1997) . Ha-RasV12G37 may activate a biochemical pathway which stimulates cyclinE/cdk2 activity, or potentially an alternative pathway which directly phosphorylates p27
Kip1 leading to its degradation. Our data suggests that Ras-mediated degradation of p27 Kip1 protein may be essential for factor-independent myeloid cell growth.
In the present study, we showed that the combined expression of the two Ha-Ras eector loop domain mutants, Ha-RasV12C40 and Ha-RasV12G37, can induce the factor-independent growth of a myeloid cell line, WT19, and mimic the eects of Ha-RasV12. Our data suggest that the downstream eectors that interact with the Ha-RasV12G37 may play an essential role in generating cell proliferation signals in myeloid cells.
Materials and methods

Cells and cell culture
The mouse lL3 (mlL-3)-dependent WT19 cell line derived from the FDC-P1 cell line was a generous gift from Dr Larry Rohrschneider (Fred Hutchinson Cancer Research Center, Seattle, WA, USA) and was previously described (Bourette et al., 1995; Matsuguchi et al., 1997) .
Plasmids
The oncogenic Ha-RasV12 expression plasmid, pHO6T1, was previously described (Spandidos and Wilkie 1984) . The expression plasmids of Ha-Ras eector domain mutants, pDCR-HA-Ha-rasV12S35, pDCR-HA-Ha-rasV12C40, and pDCR-Ha-rasV12G37 were generous gifts of Dr Bar-Sagi (Department of Molecular Genetics and Microbiology, State University of New York at Stony Brook, USA) (White et al., 1995; Joneson et al., 1996) . These cDNAs were cloned into the pEFBOS vector (Mizushima and Nagata 1990) with the N-terminal Flag tag giving plasmids, pEFBOS-Flag-Ha-rasV12S35, pEFBOS-FlagHa-rasV12C40, and pEFBOS-Flag-Ha-rasV12G37. The metal-inducible expression plasmid, pMEP-FlagRasV12G37 was prepared by cloning the Flag-tagged insert of pEF-BOS-Flag-RasV12G37 into the pMEP4 vector (Invitrogen, Carlsbad, CA, USA). pCEP-Bcl2 was prepared by cloning the human Bcl2 cDNA into the pCEP4 vector (Invitrogen). The structure of these constructs was con®rmed by restriction enzyme mapping and DNA sequence analysis.
Establishment of stable tranfectants
20 mg of pHO6T1 was introduced along with 1 mg of pSV2Neo into WT19 cells by electroporation using BioRad Gene Pulsar (Richmond, CA, USA), and transfectants were isolated using G418 (0.4 mg/ml). 20 mg of pDCR-HAHa-rasV12S35 or pDCR-HA-Ha-rasV12C40 was transfected by electroporation and transfectants were isolated using G418 (0.4 mg/ml). 20 mg of pEFBOS-Flag-HarasV12G37 was transfected along with 1 mg of pCEP4 vector into WT19 cells in the same manner and the positive clones were isolated using hygromycin selection (0.4 mg/ ml). To make double transfectant cell lines, WT19-HaRasV12S35 cells were transfected with pEF-BOS-Flag-HaRasV12G37 along with pCEP4 vector. The positive clones were isolated by hygromycin selection (0.4 mg/ml). WT19-Ha-RasV12C40 cells were transfected with pEFBOS-FlagHa-RasV12S35 or pEFBOS-Flag-Ha-rasV12G37 along with pCEP4 vector. The positive clones were isolated by hygromycin selection (0.4 mg/ml).
20 mg of pCEP-bcl-2 was introduced into WT19 cells by electroporation and transfectants were isolated using hygromycin (0.4 mg/ml). A positive clone named WT19 Bcl2 was transfected with pDCR-HA-Ha-rasV12S35, pDCR-HA-HarasV12C40, or pDCR-Ha-rasV12G37. Positive clones expressing both exogenous Bcl-2 and Ha-Ras mutants were selected by G418 selection (0.4 mg/ml).
Antibodies
The monoclonal anti-human Bcl-2 antibody and the polyclonal anti-p27 
Immunoblotting
Cells were lysed in PLC buer (50 mM HEPES, pH 7.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 10 mM NaPPi, 1 mM Na 3 VO 4 , 1 mM phenylmethanesulfonyl¯uoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin) at 10 8 cells/ml. The lysates were separated on SDS ± polyacrylamide gels, electrotransferred to Immobilon polyvinylidene di¯uoride membranes (Millipore Corporation, Bedford, MA, USA). The membranes were blocked for 2 h in 2% bovine serum albumin (BSA) ± TBST (20 mM Tris-HCl (pH 7.6), 0.15 M sodium chloride, 0.1% Tween 20), incubated with primary antibodies in TBST for 1 h, washed three times with TBST, and incubated for 1 h with horseradish peroxidaseconjugated anti-mouse or rabbit immunoglobulin (Amersham) diluted 1 : 10 000 in TBST. After three washes in TBST, the blot was developed with the enhanced chemiluminescence system (Amersham Life Science Inc., Arlington Heights, IL, USA) according to the manufacturer's instructions.
Akt immune complex kinase assay
The cell lysates (1610 7 cells/sample) were incubated with 0.4 mg polyclonal anti-Akt antibody for 2 h at 48C, followed by protein A-Sepharose beads (Pharmacia Biotech, Piscataway, NJ, USA) for an additional 1 h. The beads were washed three times in PLC lysis buer, and then once in kinase buer (20 mM HEPES, pH 7.9, 10 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM sodium vanadate, 10 mM bglycerophosphate, and 1 mM DTT). The kinase reaction was initiated by the addition of 40 ml of kinase buer containing 20 mM ATP, 5 mCi [g-32P]ATP, and 5 mg histone H2B (Boehringer Mannheim Corp., Indianapolis, IN, USA), and was allowed to proceed for 15 min at 308C. The reaction was terminated by the addition of 2X SDS ± sample buer. Samples were boiled, resolved by 15% SDS ± PAGE, and the ®xed gel was exposed to an X-ray ®lm.
Cell cycle analysis
Cells were ®xed in cold 70% ethanol and stained in phosphate-buered saline (PBS) with propidium iodide (50 mg/ml) in the presence of RNAse A (50 mg/ml) and analysed for cell cycle distribution using FACS analysis. The fraction of cells in each phase of cell cycle was quantitated using Mod-Fit cell cycle plots.
DNA fragmentation analysis
Cells were deprived of mlL-3 for 24 h, washed in PBS and lysed in the cell lysis buer (10 mM EDTA, 50 mM TrisHCl (pH 8), 0.5% SDS, 0.5 mg/ml Proteinase K) for 4 h at 508C. After an additional 3 h incubation with the addition of 0.25 mg/ml RNaseA, the genomic DNA was extracted with phenol-chloroform, and precipitated with ethanol. DNA fragments were visualized after 1.5% agarose gel electrophoresis followed by ethidium bromide staining.
